Realizing the full potential of si/shRNA technology requires more sophisticated approaches to address the pitfalls.
No takes yet. Share an insight, caveat, or question.
William G. Kaelin (2012) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: